Stockreport

Motif Bio to Host Investor and Analyst Event on September 20, 2017 in New York

MOTIF BIO PLC ADRS  (MTFB) 
US:NASDAQ Investor Relations: ir.motifbio.com
PDF NEW YORK, Sept. 08, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (Nasdaq:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibi [Read more]